Testing effectiveness (Phase 2)Looking for participantsNCT07810010
What this trial is testing
Phase 2b Study of a Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Protein Vaccine Candidate in Adults 60 Years of Age and Older
Who this might be right for
Respiratory Syncytial VirusHuman MetapneumovirusHealthy Volunteers
Sanofi 8,000